Magdalena Huber
- Immunology top 1%
- Oncology top 5%
- Molecular Biology
- Cancer Research top 5%
- Epidemiology
- Co-authors
- Michael LohoffAnne BrüstleHans‐Willi MittrückerAlexander VisekrunaAnna GuralnikTak W. MakSylvia HeinkThomas Kamradt
- Topics
- Immune Cell Function and Interaction (26 papers)T-cell and B-cell Immunology (22 papers)Immunotherapy and Immune Responses (11 papers)
- Cited by
- ImmunologyOncologyCancer Research
- Journals
- Proceedings of the National Academy of SciencesJournal of Clinical InvestigationNature Communications
- Partner nations
- GermanyCanadaSwitzerland
In The Last Decade
Magdalena Huber
60 papers receiving 3.3k citations
Hit Papers
Peers
Comparison fields: 5 of 116
- Immunology 2.3k
- Oncology 904
- Molecular Biology 570
- Cancer Research 315
- Epidemiology 234
Countries citing papers authored by Magdalena Huber
This map shows the geographic impact of Magdalena Huber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Magdalena Huber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Magdalena Huber more than expected).
Fields of papers citing papers by Magdalena Huber
This network shows the impact of papers produced by Magdalena Huber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Magdalena Huber. The network helps show where Magdalena Huber may publish in the future.
Co-authorship network of co-authors of Magdalena Huber
This figure shows the co-authorship network connecting the top 25 collaborators of Magdalena Huber. A scholar is included among the top collaborators of Magdalena Huber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Magdalena Huber. Magdalena Huber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 11 | |
| 2 | 14 | |
| 3 | 1 | |
| 4 | 2 | |
| 5 | 0 | |
| 6 | 8 | |
| 7 | 1 | |
| 8 | 7 | |
| 9 | 39 | |
| 10 | 8 | |
| 11 | 3 | |
| 12 | 50 | |
| 13 | 5 | |
| 14 | 30 | |
| 15 | 206 | |
| 16 | 190 | |
| 17 | 20 | |
| 18 | 235 | |
| 19 | The development of inflammatory TH-17 cells requires interferon-regulatory factor 4breakdown → | 540 |
| 20 | 27 |
About Magdalena Huber
Magdalena Huber is a scholar working on Immunology, Oncology and Cancer Research, having authored 62 papers that have together received 3.3k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (26 papers), T-cell and B-cell Immunology (22 papers) and Immunotherapy and Immune Responses (11 papers). The work is most often cited by research in Immunology (2.3k citations), Oncology (904 citations) and Cancer Research (315 citations). Magdalena Huber has collaborated with scholars based in Germany, Canada and Switzerland. Frequent co-authors include Michael Lohoff, Anne Brüstle, Hans‐Willi Mittrücker, Alexander Visekruna, Anna Guralnik, Tak W. Mak, Sylvia Heink, Thomas Kamradt, Katharina Reinhard and Enrico Arpaia. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.